FAG
LLY icon

Financial Advisory Group’s Eli Lilly LLY Stock Holding History

Financial Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.26M Buy
1,619
+495
+44% +$352K 0.22% 43
2023
Q4 		$655K Sell
1,124
-1
-0.1% -$584 0.12% 55
2023
Q3 		$604K Sell
1,125
-5
-0.4% -$2.58K 0.12% 56
2023
Q2 		$530K Hold
1,130
– – 0.1% 56
2023
Q1 		$388K Hold
1,130
– – 0.08% 61
2022
Q4 		$413K Sell
1,130
-279
-20% -$98.9K 0.09% 60
2022
Q3 		$456K Buy
1,409
+8
+0.6% +$2.54K 0.1% 53
2022
Q2 		$454K Buy
1,401
+9
+0.6% +$2.7K 0.1% 58
2022
Q1 		$399K Buy
1,392
+1
+0.1% +$257 0.08% 64
2021
Q4 		$384K Buy
1,391
+1
+0.1% +$254 0.08% 67
2021
Q3 		$321K Buy
1,390
+1
+0.1% +$247 0.07% 70
2021
Q2 		$319K Buy
1,389
+274
+25% +$55K 0.08% 70
2021
Q1 		$208K Sell
1,115
-272
-20% -$53.2K 0.05% 79
2020
Q4 		$234K Buy
+1,387
New +$207K 0.06% 80

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Advisory Group's LLY Position: Q1 2024 in Review

Financial Advisory Group increased its Eli Lilly (LLY) stake by 44% in Q1 2024, buying an estimated $352K and bringing the position to 1,619 shares worth $1.26M. The position accounts for 0.22% of the portfolio, ranked #43.

Financial Advisory Group first reported a position in LLY in Q4 2020 and has held it in 14 quarters since. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Financial Advisory Group held 1,619 shares of Eli Lilly worth $1.26M as of Q1 2024.
  • Financial Advisory Group bought 495 Eli Lilly shares in Q1 2024, an estimated $352K.
  • Eli Lilly made up 0.22% of Financial Advisory Group's portfolio in Q1 2024, its #43 holding.
  • Financial Advisory Group first reported a position in Eli Lilly in Q4 2020 and has held it in 14 quarters since.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Financial Advisory Group's 13F filing for Q1 2024, filed 10 May 2024.